Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released Aug 11, 2016, after the close
10-Q filed Aug 11, 2016, 42 days after period end · 0001171843-16-011715
| Metric | Q2 2016 | Q2 2015 | Q2 2014 | Q2 2013 |
|---|---|---|---|---|
| Revenue | $2.50K | $2.50K | $5.00K | $2.50K |
| Net Income | -$3.85M | -$5.45M | -$6.75M | -$6.25M |
| EPS Diluted |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| -$0.47 |
| -$0.06 |
| -$0.08 |
| -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
